Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Keefe, Bruyette & Woods Maintains Outperform on Enact Holdings, Lowers Price Target to $39

Author: Benzinga Newsdesk | April 08, 2025 11:57am
Keefe, Bruyette & Woods analyst Bose George maintains Enact Holdings (NASDAQ:ACT) with a Outperform and lowers the price target from $41 to $39.

Posted In: ACT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist